Strategic Acquisition Recent acquisition by NextPhase Medical Devices signals a consolidation in outsourced medical device manufacturing. This presents an opportunity to position Proven Process as a scalable partner for post-merger integration, expanding capacity, compliance depth, and cross-selling end-to-end services.

Regulatory Excellence EN ISO 13485:2016 certification and FDA registration highlight strong quality systems and regulatory readiness. Emphasize capabilities in design, development, validation, and manufacturing to address customers seeking compliant, risk-managed outsourced solutions.

High Value Niche Specialization in Class II and Class III medical devices with full outsourcing capabilities indicates proficiency in complex manufacturing. Target firms developing sophisticated devices requiring rigorous QA, validation, and regulatory expertise.

Growth Readiness Revenue range and mid-sized employee base suggest agility with potential for scalable partnerships. Propose flexible engagement models, including early-stage design support through full-scale manufacturing and regulatory support.

Past collaborations Historical partnerships such as with Flowonix Medical on Prometra infusion devices demonstrate capability in device design and manufacturing collaboration. Leverage case history to demonstrate proven track record to similar device manufacturers seeking design-for-manufacture expertise.